Pertussis in older adults in the developed economies of Asia-Pacific: Is the burden fully recognised?
J. Chen, K.-B. Oh, E. Turriani and 2 more
International Journal of Infectious Diseases · 2020
doi:10.1016/j.ijid.2020.09.990 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Despite being a notifiable disease, burden of pertussis beyond childhood is poorly documented in many countries. Methods and materials: We collated pertussis notification data since 2001 from government websites for six developed economies in Asia-Pacific (Australia/Hong Kong/New Zealand/Singapore/South Korea/Taiwan) to describe the pertussis disease burden in older adults from 60 years of age (YOA) onwards. Results: Australia: Between 2001–2018, cyclic increase in reported pertussis cases was observed every ∼4 years. From 2004, more than 10% of annual reports were in adults ≥60YOA. New Zealand: The notification pattern between 2001–2017 was similar to that of Australia, with cyclic changes in notifications. Since 2005, ∼10% of reported cases were in adults ≥60YOA. Hong Kong: Fewer than 50 pertussis cases were reported annually between 2001–2016. The number of annual cases increased to 110 in 2018. No breakdown by age was available. Taiwan: Data from 2010–2018 were available and showed that <100 pertussis cases were reported annually with no clear trend. No breakdown by age was available. Singapore: Data from 2009 showed that <20–30 pertussis cases were reported annually until 2014 increased significantly, with 80 cases reported in 2016. Before 2011, all cases were in children <5YOA. Cases ≥65YOA were first reported in 2016 (3 cases, 3.8% of all notifications) and rose to 8 cases (10.5%) in 2017. South Korea: Between 2001–2009, ≤21 pertussis cases were reported annually, the majority in infants <1YOA. The number of reported cases in older age groups has slowly increased since 2009. In 2018, the total number of notifications surged to 980. To be noted, despite a 2012 study reporting that seroprevalence of anti-pertussis toxin IgG was highest in adults ≥60YOA, <5% of notified cases were in this age group before 2014. Conclusion: Some sero-epidemiology data suggests that pertussis continues to circulate in the older age groups, even in countries with satisfactory paediatric vaccination coverages. Yet, it remains widely under recognised/diagnosed/reported as shown by the low number of notifications except for Australia and New Zealand. There is a need to raise awareness about the disease and improve surveillance to fully capture pertussis burden in the “overlooked” older adult population.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.